- 5.After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data (psychedelicalpha.com)
- 6.Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts (psychedelicalpha.com)
- 7.Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast (psychedelicalpha.com)
- 8.The State of the Psychedelic Industry & Open Questions (Video) (psychedelicalpha.com)
- 9.Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials (psychedelicalpha.com)
- 12.AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal (psychedelicalpha.com)
- 13.February 2026 Psychedelic Bill Round-up (psychedelicalpha.com)